Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD
Nephrology Dialysis Transplantation · 31.05.2024 · 39 (6) · 1008-1015
DOI: 10.1093/ndt/gfad232 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 03.11.2023. Verfasst von Taro Akihisa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Tolvaptan, Polycystic Kidney, Autosomal Dominant, Antidiuretic Hormone Receptor Antagonists, Glomerular Filtration Rate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: JSPS.
Abstract (Originalsprache)
Background
Tolvaptan, a vasopressin V2 receptor antagonist, is used for treating autosomal dominant polycystic kidney disease (ADPKD). We focused on changes in urinary osmolality (U-Osm) after tolvaptan initiation to determine whether they were associated with the therapeutic response to tolvaptan.
Methods
This was a single-centre, prospective, observational cohort study. Seventy-two patients with ADPKD who received tolvaptan were recruited. We analysed the relationship between changes in U-Osm and annual estimated glomerular filtration rate (eGFR) in terms of renal prognostic value using univariable and multivariable linear regression analyses.
Results
The mean value of U-Osm immediately before tolvaptan initiation was 351.8 ± 142.2 mOsm/kg H2O, which decreased to 97.6 ± 23.8 mOsm/kg H2O in the evening. The decrease in U-Osm was maintained in the outpatient clinic 1 month later. However, the 1-month values of U-Osm showed higher variability (160.2 ± 83.8 mOsm/kg H2O) than did those in the first evening of tolvaptan administration. Multivariate analysis revealed that the baseline eGFR, baseline urinary protein and U-Osm change in the evening of the day of admission (initial U-Osm drop) were significantly correlated with the subsequent annual change in eGFR.
Conclusions
U-Osm can be measured easily and rapidly, and U-Osm change within a short time after tolvaptan initiation may be a useful index for the renal prognosis in actual clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
- Department of Blood Purification, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
ORCID-Profile: Hiroshi Kataoka
Förderung
- JSPS
Zitieren
APA
Akihisa, T., Kataoka, H., Makabe, S., Manabe, S., Yoshida, R., Ushio, Y., Sato, M., Yajima, A., Hanafusa, N., Tsuchiya, K., Nitta, K., Hoshino, J., & Mochizuki, T. (2024). Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. Nephrology Dialysis Transplantation, 39(6), 1008-1015. https://doi.org/10.1093/ndt/gfad232
Vancouver
Akihisa T, Kataoka H, Makabe S, Manabe S, Yoshida R, Ushio Y, et al. Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. Nephrology Dialysis Transplantation. 2024;39(6):1008-1015. doi:10.1093/ndt/gfad232
BibTeX
@article{Akihisa2024,
author = {Akihisa, Taro and Kataoka, Hiroshi and Makabe, Shiho and Manabe, Shun and Yoshida, Rie and Ushio, Yusuke and Sato, Masayo and Yajima, Aiji and Hanafusa, Norio and Tsuchiya, Ken and Nitta, Kosaku and Hoshino, Junichi and Mochizuki, Toshio},
title = {Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD},
journal = {Nephrology Dialysis Transplantation},
year = {2024},
volume = {39},
number = {6},
pages = {1008--1015},
doi = {10.1093/ndt/gfad232}
}
EUVIMED